What Is The Status Of Deiveson Figueiredo vs. Cody Garbrandt?

Has Deiveson Figueiredo vs. Cody Garbrandt hit a snag?

Figueiredo is the UFC Flyweight Champion. He’s due for a title defense against former UFC Bantamweight Champion Garbrandt. While the Brazilian bruiser doesn’t believe “No Love” deserves the title shot, it’s still a big opportunity for him to establish himself as the very best at 125 pounds without question. Many feel he already did that with two finishing victories over Joseph Benavidez.

It was announced that the Figueiredo vs. Garbrandt title fight will be taking place at UFC 255 on November 21. The co-main event will see Women’s Flyweight Champion Valentina Shevchenko put her gold on the line against Jennifer Maia.

Ag Fight reported that Garbrandt recently tested positive for COVID-19. The report notes that Garbrandt was experiencing mild symptoms such as a headache. It’s noted that he is isolating until new results come in. The good news for Garbrandt is that the fight is over two months away. He could recover in time without the bout being in jeopardy.

Garbrandt is coming off a highlight-reel one-punch knockout victory over Raphael Assuncao at UFC 250. Prior to the fight, “No Love” had expressed his interest in making the move down to flyweight. While it appeared he was having seconds thoughts after sleeping Assuncao, Garbrandt ultimately decided to stick with his initial plan.

As mentioned, Figueiredo has two finishing victories over Benavidez. He scored a TKO victory in his first outing with Benavidez, although he didn’t capture the 125-pound gold due to missing weight. Then in the rematch, he choked out Benavidez in the first round to become the new flyweight king.

You might also like
By using our site you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Service. X

SIGN UP NOW!

Breaking News And Highlights Around Boxing, MMA, Kickboxing, Martial Arts and more!

By signing up, you agree to comply with our Terms of Service and Privacy Policy.